Cancer Communications
indexed by SCI

Important notice



We would like to inform you that Chinese Journal of Cancer has changed the title to Cancer Communications on 1st March 2018.
Cancer Communications is published by Wiley from 1 January 2020. The journal website is available at:



Cancer Communications 2021年影响因子突破15分

Cancer Communications 进入2021年中科院期刊分区表医学1区和肿瘤学1区

Cancer Communications 入选中国科协发布的高质量肿瘤学科技期刊T1分级目录

Cancer Communications (CJC) 获评“2019中国最具国际影响力学术期刊”

PLEK2 promotes cancer stemness and tumorigenesis of head and neck squamous cell carcinoma via the c-Myc-mediated positive feedback loop
Xinyuan Zhao, Dalong Shu, Wenjuan Sun, Shanshan Si, Wei Ran, Bing Guo, Li Cui
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 8/24/2022   doi:10.1002/cac2.12349
miR-99a-5p modulates doxorubicin resistance via the COX-2/ABCG2 axis in triple-negative breast cancer: from the discovery to in vivo studies
Iris Garrido-Cano, Anna Adam-Artigues, Ana Lameirinhas, Juan F. Blandez, Vicente Candela-Noguera, Federico Rojo, Sandra Zazo, Juan Madoz-Gúrpide, Ana Lluch, Bego?a Bermejo, Felix Sancenón, Juan Miguel Cejalvo, Ramón Martínez-Má?ez, Pilar Eroles
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 8/23/2022   doi:10.1002/cac2.12352
Evaluation of immune response to anti-COVID-19 booster in cancer patients and chronic medical cannabis users and its association with circulating Eosinophils levels
Cohen Idan, Campisi-Pinto Salvatore, Rozenberg Orit, Abaev Ariel, Khoury Marah, Agbaria Dana, Eitam Harel, Colodner Raul, Khoury Mona, Shalabna Hassan, Samih Yousef, Mahamid Camel, Abu-Amna Mahmoud, Bar-Sela Gil
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 8/22/2022   doi:10.1002/cac2.12353
Peripheral na?ve CD8+ T cells as a predictive biomarker of response to lenvatinib plus an anti-PD-1 antibody in advanced hepatocellular carcinoma: a biomarker study
Cheng Huang, Bin Xu, Xiao-Dong Zhu, Ying-Hao Shen, Mei-Ling Li, Jin-Jin Zhu, Jian Zhou, Jia Fan, Hui-Chuan Sun
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 8/22/2022   doi:10.1002/cac2.12350
A non-metabolic function of hexokinase 2 in small cell lung cancer: promotes cancer cell stemness by increasing USP11-mediated CD133 stability
Juhong Wang, Fei Shao, Yannan Yang, Wei Wang, Xueying Yang, Renda Li, Hong Cheng, Sijin Sun, Xiaoli Feng, Yibo Gao, Jie He, Zhimin Lu
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 8/16/2022   doi:10.1002/cac2.12351
Pivotal roles of tumor-draining lymph nodes in the abscopal effects from combined immunotherapy and radiotherapy
Zhaoyun Liu, Zhiyong Yu, Dawei Chen, Vivek Verma, Chenxi Yuan, Minglei Wang, Fei Wang, Qing Fan, Xingwu Wang, Yang Li, Yuequn Ma, Meng Wu, Jinming Yu
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 8/13/2022   doi:10.1002/cac2.12348
Dietary intake of advanced glycation endproducts (AGEs) and cancer risk across more than 20 anatomical sites: A multinational cohort study
Reynalda Córdova, Ana-Lucia Mayén, Viktoria Knaze, Elom Kouassivi Aglago, Casper Schalkwijk, Karl-Heinz Wagner, Kim Overvad, Anne Tj?nneland, Cecilie Kyr?, Verena Andrea Katzke, Charlotte Le Cornet, Matthias Bernd Schulze, Anna Birukov, Domenico Palli, Sara Grioni, Fabrizio Pasanisi, Alberto Catalano, Torkjel Manning Sandanger, Inger Torhild Gram, Guri Skeie, Marta Crous-Bou, Esther Molina-Montes, Pilar Amiano, Sandra Milena Colorado-Yohar, Eva Ardanaz, Isabel Drake, Jonas Manjer, Ingegerd Johansson, Anders Esberg, Aurora Perez-Cornago, Elisabete Weiderpass, Mazda Jenab, Heinz Freisling
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 8/4/2022   doi:10.1002/cac2.12343
Low-dose metronomic chemotherapy improves tumor control in nasopharyngeal carcinoma
Yu-Pei Chen, Jia-Yi Shen, Zhen-Ji Deng, Ying Sun, Xiao-Yu Liang, Jia-Wei Lv, Jun Ma
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 8/4/2022   doi:10.1002/cac2.12347
A serum microRNA signature for enhanced selection of people for lung cancer screening
Haixin Yu, Janhavi R. Raut, Megha Bhardwaj, Yan Zhang, Evelin Sandner, Ben Sch?ttker, Bernd Holleczek, Petra Schrotz-King, Hermann Brenner
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 8/4/2022   doi:10.1002/cac2.12346
Diagnostic value of genetic mutation analysis and mutation profiling of cell-free DNA in intraocular fluid for vitreoretinal lymphoma
Xiaoqing Chen, Yunwei Hu, Wenru Su, Shizhao Yang, Xiaoxiao Wang, Ping Zhang, Xiaoyu Hong, Chuqiao Liang, Zhuyun Qian, Ziqiang Li, Yong Tao, Huiqiang Huang, Dan Liang
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 8/3/2022   doi:10.1002/cac2.12344

more papers...

Gastric cancer  


Edited by Yun Dai and Li Yan

This thematic series discusses the molecular classifications of gastric cancer by the Cancer Genome Atlas (TCGA) and the Asian Cancer Research Group (ACRG) as well as the implications in personalized therapeutic choices; discusses the evolution of gastric surgery and presents perspectives on surgical techniques in treating gastric cancer; and reviews current and emerging targeted agents as well as immunotherapies in treating gastric cancer. With these advancements in molecular characterization, surgical intervention, and targeted and immunotherapies, gastric cancer will enter a personalized medicine era in the next 5 years.


Read thematic series > 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 

Tumor angiogenesis  


Edited by Francesco Pezzella
and Chao-Nan Qian 

Forming efficient vasculature network, also known as tumor angiogenesis, is a critical hallmark in tumor development. Explorations on its underlying molecular mechanisms have resulted in several novel anti-cancer drugs. However, the modest survival benefits from anti-angiogenic therapy have forced us to revisit our understanding on tumor angiogenesis. In this special issue, world-leading experts have contributed their critical thoughts to reveal alternative tumor angiogenesis approaches and potential treatment targets.


Read thematic series > 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 

Lung cancer 


Edited by Lin Yan and Wei Zhang  


Lung cancer accounts for approximately 21% of worldwide cancer deaths and a staggering 1.6 million new cases are diagnosed every year. In China, lung cancer has become a particularly challenging disease because of air pollution and smoking. This thematic series discusses the proper use of targeted agents in treating lung cancer, reviews the application of biomarkers in clinical management and drug development, and analyzes the unique challenges in developing novel drugs for lung cancer in China.


Read thematic series > 

CJC Wechat 微信公众号


Editorial Manager

CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  


Reference style for  

 Reference Manager

Editorial Manager





Advanced search


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East,Guangzhou 510060, P.R.China